Peter Tyrer

ADCT-402, a PBD dimer–containing antibody drug conjugate targeting CD19-expressing malignancies

Francesca Zammarchi, Simon Corbett, Lauren Adams et al. · Blood · 2018 · 174 citations · Full text

ADCT-301, a Pyrrolobenzodiazepine (PBD) Dimer–Containing Antibody–Drug Conjugate (ADC) Targeting CD25-Expressing Hematological Malignancies

Michael Flynn, Francesca Zammarchi, Peter Tyrer et al. · Molecular Cancer Therapeutics · 2016 · 125 citations · Full text

Microbial Pattern Recognition Receptors Mediate M-Cell Uptake of a Gram-Negative Bacterium

Peter Tyrer, A. Ruth Foxwell, Allan W. Cripps et al. · Infection and Immunity · 2005 · 96 citations · Full text

Inflammation, Dysbiosis, Murine M Cells +15

Validation and quantitation of an in vitro M-cell model

Peter Tyrer, A. Ruth Foxwell, Jennelle M. Kyd et al. · Biochemical and Biophysical Research Communications · 2002 · 50 citations

Cell Therapy, Medicine, Cell Culture +8

Antitumor Activity of MEDI3726 (ADCT-401), a Pyrrolobenzodiazepine Antibody–Drug Conjugate Targeting PSMA, in Preclinical Models of Prostate Cancer

Song Cho, Francesca Zammarchi, David G. Williams et al. · Molecular Cancer Therapeutics · 2018 · 46 citations